Erman Çiftçi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Erman Çiftçi has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Münip Akalın
Department of Perinatology Marmara University Pendik Training and Research Hospital Istanbul Turkey
4 shared publications - Ali Karaman
Department of Medical Genetics, Erzurum Nenehatun Obstetrics and Gynecology Hospital, Erzurum, Turkey
2 shared publications - Gizem Elif Dizdaroğulları
Department of Perinatology, University of Health Sciences Zeynep Kamil Women’s and Children’s Disease Training and Research Hospital, Istanbul, Turkey
2 shared publications - Oya Demirci
Department of Obstetrics, Division of Perinatology Zeynep Kamil Kadın ve Çocuk Hastalıkları Eğitim ve Araştırma Hastanesi Istanbul Turkey
2 shared publications - Ahmet Adiguzel
14Department of Neurology, Faculty of Medicine, İnönü University, Malatya, Turkiye
1 shared publication Ahmet Balun
1 shared publication
Latest Publications
- 1 December 2022
- Published by Elite Scientific Forum in Perinatal Journal
- Vol. 30 (3) , 257-265
Advantages and limitations of QF-PCR analysis in invasive prenatal genetic diagnosis: a tertiary center experience from Turkey
Objective: The aim of this study was to investigate the success and reliability of QF-PCR analysis in detecting chromosomal abnormalities and to determine its advantages and limitations. Methods: Patients who underwent karyotype and QF-PCR analysis as a prenatal invasive diagnostic test in a tertiary center were retrospectively analyzed. Invasive genetic test indications, ultrasonographic fetal screening reports, karyotype and QF-PCR analysis results of the patients were obtained from the electronic data system. Karyotypes were classified as normal, common aneuploidies (trisomies 21, 18, 13, and sex chromosome aneuploidies) and other aneuploidies. QF-PCR analysis and karyotype results were compared for inconsistency. Results: A total of 426 cases (41 [9.6%] chorionic villus sampling, 339 [79.6%] amniocentesis and 46 [10.8%] cordocentesis) were included in the study. The most common indication for prenatal invasive diagnostic testing was fetal structural anomalies (36.7%). Aneuploidy was detected in 61 (14.3%) of the fetuses. Fifty-nine (96.7%) of 61 fetuses with aneuploidy were common aneuploidies. The sensitivity and specificity of the QF-PCR analysis in detecting common aneuploidies was 100%. QF-PCR analysis was indicative if not diagnostic in all fetuses with mosaic trisomy or sex chromosome aneuploidies. Conclusion: QF-PCR analysis is a rapid, robust, and reliable test for the prenatal detection of common aneuploidies. Although QF-PCR analysis has high sensitivity and specificity in detecting common aneuploidies, it should be used for rapid preliminary information and the result of karyotype analysis should be awaited for important clinical decisions.
- 1 December 2022
- Published by Elite Scientific Forum in Perinatal Journal
- Vol. 30 (3) , 257-265
Advantages and limitations of QF-PCR analysis in invasive prenatal genetic diagnosis: a tertiary center experience from Turkey
Objective: The aim of this study was to investigate the success and reliability of QF-PCR analysis in detecting chromosomal abnormalities and to determine its advantages and limitations. Methods: Patients who underwent karyotype and QF-PCR analysis as a prenatal invasive diagnostic test in a tertiary center were retrospectively analyzed. Invasive genetic test indications, ultrasonographic fetal screening reports, karyotype and QF-PCR analysis results of the patients were obtained from the electronic data system. Karyotypes were classified as normal, common aneuploidies (trisomies 21, 18, 13, and sex chromosome aneuploidies) and other aneuploidies. QF-PCR analysis and karyotype results were compared for inconsistency. Results: A total of 426 cases (41 [9.6%] chorionic villus sampling, 339 [79.6%] amniocentesis and 46 [10.8%] cordocentesis) were included in the study. The most common indication for prenatal invasive diagnostic testing was fetal structural anomalies (36.7%). Aneuploidy was detected in 61 (14.3%) of the fetuses. Fifty-nine (96.7%) of 61 fetuses with aneuploidy were common aneuploidies. The sensitivity and specificity of the QF-PCR analysis in detecting common aneuploidies was 100%. QF-PCR analysis was indicative if not diagnostic in all fetuses with mosaic trisomy or sex chromosome aneuploidies. Conclusion: QF-PCR analysis is a rapid, robust, and reliable test for the prenatal detection of common aneuploidies. Although QF-PCR analysis has high sensitivity and specificity in detecting common aneuploidies, it should be used for rapid preliminary information and the result of karyotype analysis should be awaited for important clinical decisions.
- 31 October 2022
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 49 (2) , 519-529
Contribution of chromosomal microarray analysis and next‐generation sequencing to genetic diagnosis in fetuses with normal karyotype
Aim: The aim of this study was to investigate the contribution of chromosomal microarray analysis (CMA) and next‐generation sequencing (NGS) to genetic diagnosis in fetuses with normal karyotype who underwent invasive testing for different indications.Methods: The results of invasive genetic testing performed at a tertiary center between September 2020 and March 2022 were retrospectively analyzed. Indications for invasive tests were classified as fetal structural malformation, presence of soft markers, and high risk in screening tests. CMA results were classified as pathogenic or likely pathogenic (pCNVs), benign (bCNVs), and variants of unknown clinical significance (VOUS).Results: A total of 830 invasive tests were performed and aneuploidy was detected in 11.2% of the fetuses. CMA was performed in 465 fetuses with normal karyotype, and pCNVs were detected in 6.9%. pCNVs were detected in 8.2% of fetuses with structural malformations, 6.5% in soft markers, and 4.7% in high risk in screening tests. Pathogenic variants were detected by NGS in 33.8% of fetuses with bCNVs.Conclusions: pCNVs can be significantly detected not only in fetuses with structural malformations, but also in invasive testing with other indications. NGS significantly contributes to genetic diagnosis in fetuses with structural malformations.
- 31 October 2022
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 49 (2) , 519-529
Contribution of chromosomal microarray analysis and next‐generation sequencing to genetic diagnosis in fetuses with normal karyotype
Aim: The aim of this study was to investigate the contribution of chromosomal microarray analysis (CMA) and next‐generation sequencing (NGS) to genetic diagnosis in fetuses with normal karyotype who underwent invasive testing for different indications.Methods: The results of invasive genetic testing performed at a tertiary center between September 2020 and March 2022 were retrospectively analyzed. Indications for invasive tests were classified as fetal structural malformation, presence of soft markers, and high risk in screening tests. CMA results were classified as pathogenic or likely pathogenic (pCNVs), benign (bCNVs), and variants of unknown clinical significance (VOUS).Results: A total of 830 invasive tests were performed and aneuploidy was detected in 11.2% of the fetuses. CMA was performed in 465 fetuses with normal karyotype, and pCNVs were detected in 6.9%. pCNVs were detected in 8.2% of fetuses with structural malformations, 6.5% in soft markers, and 4.7% in high risk in screening tests. Pathogenic variants were detected by NGS in 33.8% of fetuses with bCNVs.Conclusions: pCNVs can be significantly detected not only in fetuses with structural malformations, but also in invasive testing with other indications. NGS significantly contributes to genetic diagnosis in fetuses with structural malformations.
- 11 April 2022
- Published by Academician Publishing
- p. 251-262
Konjenital Diyafragma Hernisinde İntrauterin Tedavi
Konjenital diyafragma hernisi (KDH), diyafragma kasındaki gelişimsel kusur nedeniyle karın içi organların göğüs kafesine fıtıklaşması ve buna bağlı olarak akciğer gelişiminin bozulmasıyla karakterize bir malformasyondur. Gebelik döneminde ultrason ve MR ile tanı konulabilen bu durumda, özellikle ağır vakalarda akciğer gelişimini uyarmak amacıyla minimal invaziv bir yöntem olan FETO (fetoskopik endoluminal trakeal oklüzyon) işlemi uygulanmaktadır. TOTAL Trial çalışmasının sonuçlarına göre, FETO işlemi ciddi pulmoner hipoplazisi olan fetuslarda doğum sonrası sağ kalımı anlamlı düzeyde artırırken, orta dereceli vakalarda benzer bir üstünlük gösterilememiştir. Congenital diaphragmatic hernia (CDH) is a malformation characterized by the herniation of abdominal organs into the chest cavity due to a developmental defect in the diaphragm muscle, leading to impaired lung development. While the condition is diagnosed prenatally via ultrasound and MRI, the FETO (fetoscopic endoluminal tracheal occlusion) procedure is a minimally invasive intervention used to stimulate lung growth, especially in severe cases. According to the results of the TOTAL Trial, FETO significantly improves postnatal survival in fetuses with severe pulmonary hypoplasia, although no such significant benefit was observed in moderate cases.
- 11 April 2022
- Published by Academician Publishing
- p. 251-262
Konjenital Diyafragma Hernisinde İntrauterin Tedavi
Konjenital diyafragma hernisi (KDH), diyafragma kasındaki gelişimsel kusur nedeniyle karın içi organların göğüs kafesine fıtıklaşması ve buna bağlı olarak akciğer gelişiminin bozulmasıyla karakterize bir malformasyondur. Gebelik döneminde ultrason ve MR ile tanı konulabilen bu durumda, özellikle ağır vakalarda akciğer gelişimini uyarmak amacıyla minimal invaziv bir yöntem olan FETO (fetoskopik endoluminal trakeal oklüzyon) işlemi uygulanmaktadır. TOTAL Trial çalışmasının sonuçlarına göre, FETO işlemi ciddi pulmoner hipoplazisi olan fetuslarda doğum sonrası sağ kalımı anlamlı düzeyde artırırken, orta dereceli vakalarda benzer bir üstünlük gösterilememiştir. Congenital diaphragmatic hernia (CDH) is a malformation characterized by the herniation of abdominal organs into the chest cavity due to a developmental defect in the diaphragm muscle, leading to impaired lung development. While the condition is diagnosed prenatally via ultrasound and MRI, the FETO (fetoscopic endoluminal tracheal occlusion) procedure is a minimally invasive intervention used to stimulate lung growth, especially in severe cases. According to the results of the TOTAL Trial, FETO significantly improves postnatal survival in fetuses with severe pulmonary hypoplasia, although no such significant benefit was observed in moderate cases.